These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36941133)

  • 21. Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis.
    Kritikos A; Poissy J; Croxatto A; Bochud PY; Pagani JL; Lamoth F
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32238435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (1-3)-β-D-glucan levels in candidiasis infections in the critically ill neonate.
    Goudjil S; Kongolo G; Dusol L; Imestouren F; Cornu M; Leke A; Chouaki T
    J Matern Fetal Neonatal Med; 2013 Jan; 26(1):44-8. PubMed ID: 22913303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocyte human leukocyte antigen-DR but not β-D-glucan may help early diagnosing invasive Candida infection in critically ill patients.
    Jung B; Le Bihan C; Portales P; Bourgeois N; Vincent T; Lachaud L; Chanques G; Conseil M; Corne P; Massanet P; Timsit JF; Jaber S
    Ann Intensive Care; 2021 Aug; 11(1):129. PubMed ID: 34417900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
    Kritikos A; Caruana G; Poissy J; Mamin A; Bachmann D; Pagani JL; Coste AT; Lamoth F
    J Clin Microbiol; 2023 Feb; 61(2):e0169122. PubMed ID: 36700626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Presence of (1→3)-β-D-Glucan as Prognostic Marker in Patients After Major Abdominal Surgery.
    White PL; Posso R; Parr C; Price JS; Finkelman M; Barnes RA
    Clin Infect Dis; 2021 Oct; 73(7):e1415-e1422. PubMed ID: 32914187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of β-D-glucan alone or combined with Candida score, colonization index and C-reactive protein for candidemia.
    Kazancioglu S; Bastug A; Kayaaslan B; Mutlu NM; Calci E; Turhan T; Mumcuoglu I; Akinci E; Bodur H
    J Infect Dev Ctries; 2022 Feb; 16(2):362-368. PubMed ID: 35298433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients.
    Salvatore CM; Chen TK; Toussi SS; DeLaMora P; Petraitiene R; Finkelman MA; Walsh TJ
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):277-86. PubMed ID: 26407252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.
    Giacobbe DR; Mikulska M; Tumbarello M; Furfaro E; Spadaro M; Losito AR; Mesini A; De Pascale G; Marchese A; Bruzzone M; Pelosi P; Mussap M; Molin A; Antonelli M; Posteraro B; Sanguinetti M; Viscoli C; Del Bono V;
    Crit Care; 2017 Jul; 21(1):176. PubMed ID: 28693606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
    Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
    Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.
    Posteraro B; Tumbarello M; De Pascale G; Liberto E; Vallecoccia MS; De Carolis E; Di Gravio V; Trecarichi EM; Sanguinetti M; Antonelli M
    J Antimicrob Chemother; 2016 Aug; 71(8):2262-9. PubMed ID: 27125554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
    Bloos F; Held J; Kluge S; Simon P; Kogelmann K; de Heer G; Kuhn SO; Jarczak D; Motsch J; Hempel G; Weiler N; Weyland A; Drüner M; Gründling M; Meybohm P; Richter D; Jaschinski U; Moerer O; Günther U; Schädler D; Weiss R; Putensen C; Castellanos I; Kurzai O; Schlattmann P; Cornely OA; Bauer M; Thomas-Rüddel D;
    Intensive Care Med; 2022 Jul; 48(7):865-875. PubMed ID: 35708758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of fungal DNA in peritoneal fluids by a PCR DNA low-density microarray system and quantitation of serum (1-3)-β-D-glucan in the diagnosis of peritoneal candidiasis.
    Corrales I; Giménez E; Aguilar G; Delgado C; Puig J; Izquierdo A; Belda J; Navarro D
    Med Mycol; 2015 Feb; 53(2):199-204. PubMed ID: 25541561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis.
    Yan T; Li SL; Ou HL; Zhu SN; Huang L; Wang DX
    World J Surg; 2020 May; 44(5):1459-1469. PubMed ID: 31965275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.
    Reischies FM; Prattes J; Woelfler A; Eigl S; Hoenigl M
    Transpl Infect Dis; 2016 Jun; 18(3):466-70. PubMed ID: 26992092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
    White SK; Schmidt RL; Walker BS; Hanson KE
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-abdominal candidiasis in surgical intensive care unit - epidemiology characteristics and trends.
    Ulrych J; Adámková V; Matek J; Komarc M; Frýba V; Schmidt D; Koželský P; Studená A; Bříza J; Krška Z
    Epidemiol Mikrobiol Imunol; 2020; 69(2):57-63. PubMed ID: 32819104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species.
    Mokaddas E; Burhamah MH; Khan ZU; Ahmad S
    BMC Infect Dis; 2010 Oct; 10():292. PubMed ID: 20923575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
    Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
    J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.
    Prattes J; Hoenigl M; Rabensteiner J; Raggam RB; Prueller F; Zollner-Schwetz I; Valentin T; Hönigl K; Fruhwald S; Krause R
    Mycoses; 2014 Nov; 57(11):679-86. PubMed ID: 25040144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Sensitivity of the (1-3)-β-D-glucan Test for Predicting Candidemia.
    Lee YW; Lim SY; Jin S; Park HJ; Sung H; Kim MN; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Chong YP
    Ann Lab Med; 2023 Jul; 43(4):381-385. PubMed ID: 36843407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.